Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,120 public trials 3,997 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Second STOP After Pioglitazone Priming in CML Patients

NCT02889003

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Centre Hospitalier de Versailles Le Chesnay, France
  • Hôpital Bicêtre Le Kremlin-Bicêtre, France
  • CHU Lyon Lyon, France
  • CHU de Nantes Nantes, France
View Trial Details
Recruiting

EWALL-PH OBSERVARTORY 2022

NCT07684131

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Groupe hospitalier sud Amiens, France
  • CHU Angers Angers, France
  • CH de la cote basque Bayonne, France
  • CHU Bordeaux Bordeaux, France
View all 23 locations
View Trial Details
Recruiting

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

NCT06697600

Conditions
Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • University of Alabama at Birmingham, Division of Hematology and Oncology Birmingham, Alabama, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology Winston-Salem, North Carolina, United States
View Trial Details
Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

NCT02332668

Conditions
Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +18 more
Locations
  • Call for Information (Investigational Site 0019) Aurora, Colorado, United States
  • Call for Information (Investigational Site 0024) Chicago, Illinois, United States
  • Call for Information (Investigational Site 0026) Boston, Massachusetts, United States
  • Call for Information (Investigational Site 0031) New York, United States
View all 16 locations
View Trial Details

Related conditions